ABEONA THERAPEUTICS INC. Increase (Decrease) in Interest Payable, Net
ABEONA THERAPEUTICS INC. (ABEO) reported Increase (Decrease) in Interest Payable, Net of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2014-03-26
- ABEONA THERAPEUTICS INC. increase (decrease) in interest payable, net for the quarter ending 2013-12-31 was $0.00.
- ABEONA THERAPEUTICS INC. increase (decrease) in interest payable, net for the quarter ending 2013-09-30 was $0.00.
- ABEONA THERAPEUTICS INC. increase (decrease) in interest payable, net for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. increase (decrease) in interest payable, net for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. increase (decrease) in interest payable, net for fiscal 2013 was $0.00.
- ABEONA THERAPEUTICS INC. increase (decrease) in interest payable, net for fiscal 2012 was -$98.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in interest payable, net for fiscal 2011 was -$28.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in interest payable, net for fiscal 2010 was -$437.00K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $0.00 derived: sum of 2 quarters · filed 2014-03-26 | $0.00 derived: sum of 3 quarters · filed 2014-03-26 | $0.00 10-K · filed 2014-03-26 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | -$19.00K derived: sum of 4 quarters · filed 2014-03-26 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | -$19.00K derived: sum of 3 quarters · filed 2014-03-26 | -$264.00K derived: sum of 4 quarters · filed 2014-03-26 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-15 | -$19.00K derived: sum of 2 quarters · filed 2014-03-26 | -$264.00K derived: sum of 3 quarters · filed 2014-03-26 | -$181.00K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$264.00K derived: sum of 2 quarters · filed 2014-03-26 | -$181.00K derived: sum of 3 quarters · filed 2014-03-26 | -$98.00K 10-K · filed 2014-03-26 |
| 2012-09-30 | -$245.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$162.00K derived: sum of 2 quarters · filed 2013-11-14 | -$79.00K 10-Q · filed 2013-11-14 | -$11.00K derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $166.00K 10-Q · filed 2013-08-14 | $234.00K derived: sum of 3 quarters · filed 2013-08-14 | -$261.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $83.00K 10-Q · filed 2013-05-15 | $151.00K derived: sum of 2 quarters · filed 2013-05-15 | -$344.00K derived: sum of 3 quarters · filed 2013-05-15 | -$51.00K derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | -$427.00K derived: sum of 2 quarters · filed 2013-03-20 | -$134.00K derived: sum of 3 quarters · filed 2013-03-20 | -$28.00K 10-K · filed 2013-03-20 |
| 2011-09-30 | -$495.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$202.00K derived: sum of 2 quarters · filed 2012-11-14 | -$96.00K 10-Q · filed 2012-11-14 | -$416.00K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $293.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $399.00K 10-Q · filed 2012-08-14 | $79.00K derived: sum of 3 quarters · filed 2012-08-14 | $187.00K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $106.00K 10-Q · filed 2012-05-15 | -$214.00K derived: sum of 2 quarters · filed 2012-05-15 | -$106.00K derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | -$320.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23 | -$212.00K derived: sum of 2 quarters · filed 2012-03-23 | -$437.00K 10-K · filed 2012-03-23 | |
| 2010-09-30 | $108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$117.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$225.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |